{"id":26240,"date":"2025-09-22T17:45:59","date_gmt":"2025-09-22T21:45:59","guid":{"rendered":"https:\/\/valuecare.wpgamma.com\/?p=26240"},"modified":"2025-09-22T17:45:59","modified_gmt":"2025-09-22T21:45:59","slug":"alzheimer-research","status":"publish","type":"post","link":"https:\/\/valuecare.wpgamma.com\/index.php\/2025\/09\/22\/alzheimer-research\/","title":{"rendered":"Alzheimer Research"},"content":{"rendered":"
\n

\"Alzheimer<\/a>Alzheimer research is important to continue to explore options for treatment protocols as well as potentially implicate causative factors that will lead to better preventative measures and early diagnosis.\u00a0Alzheimer\u2019s<\/a>\u00a0is a degenerative disease that has significant impact on the lives of those it touches not only the patients but also their friends and relatives.<\/p>\n

Research has currently uncovered a link between\u00a0cholesterol levels<\/a>\u00a0and an increased risk of developing\u00a0Alzheimer\u2019s<\/a>\u00a0disease. Unfortunately there is disagreement about whether the levels are too high or too low when they cause this increased risk. Based on the research it may be that both.<\/p>\n

Other research has found that the use of 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors, or statin drugs, have decreased the risk of developing\u00a0Alzheimer\u2019s<\/a>. In a study by researchers from Texas and published in 2003 in the Archives of Neurology they theorized that byproducts from cholesterol caused the damage to the brain that initiated the development of\u00a0Alzheimer\u2019s<\/a>. In their study they showed that two statin drugs were more effective in decreasing those byproducts than niacin.<\/p>\n

People currently suffering from\u00a0Alzheimers<\/a>\u00a0in most of the different stages may be eligible to participate in clinical trials testing the efficacy and effectiveness of new medications or medications that are commonly used in other diseases. For instance, there has been some research to suggest that the use of\u00a0insulin<\/a>\u00a0delivered intranasally has the potential to treat brain diseases and injuries because of the growth factor. The intranasal delivery of nerve growth factor from\u00a0insulin<\/a>\u00a0is currently being tested in animals.<\/p>\n

Another investigational drug studied in patients with mild\u00a0Alzheimers<\/a>\u00a0disease is a selective amyloid lowering agent that decreases the level of the toxic peptide beta 42. A phase 2 follow up study has shown this drug, Flurizan, has continued to demonstrate increasing benefits in memory and cognition 21 months after treatment began.<\/p>\n

Research studies currently being done at Stanford University are investigating psychosocial factors involved in the disease, exercise in the treatment of\u00a0Alzheimers<\/a>, sexuality and\u00a0sleep disorders<\/a>. Mayo clinic has clinical studies ongoing also that relate to the amyloid plaques and family studies.<\/p>\n

Most large universities have clinical trials ongoing to investigate the issues and problems associated with the disease. These studies are the backbone of treatment protocols that continue to be evaluated and developed.<\/p>\n

Alzheimer research is focused not only on the causes and treatments but also the psychological effects and\u00a0stressors<\/a>\u00a0placed on the patient and their families. Research has proven that with support families are able to keep their loved ones home for longer periods of time which decreases the cost of care as well as have a decreased risk of deep depression related to the stress of caring for their loved one.<\/p>\n

MemoRise<\/a>\u00a0assists with cognitive functioning, improves memory, concentration and attention span, prevents\u00a0hardening of the arteries<\/a>\u00a0and reduces the risk of stroke or\u00a0heart attack<\/a>, improves heart functioning-especially irregular heart beat, achieves healthy circulation and assist withs\u00a0hemorrhoids<\/a>,\u00a0varicose veins<\/a>\u00a0and chilblains.<\/p>\n

MemoRise<\/a>\u00a0also reduces the symptoms of\u00a0dementia<\/a>\u00a0in\u00a0Alzheimers<\/a>\u00a0Disease.\u00a0 Scientifically shown to\u00a0improve memory<\/a>\u00a0loss linked to aging which can lead to improved cognitive functioning and a \u2018sharper\u2019 mind. Recommended for mature minds to\u00a0improve memory<\/a>\u00a0and blood flow to the brain and as a general tonic Formulated by a clinical psychologist,\u00a0MemoRise<\/a>\u00a0is pharmaceutically manufactured to the highest standards and is safe and effective.<\/p>\n

Enrich your life and the lives of others<\/strong><\/span>\u00a0by learning Aromatherapy, Reflexology or Color\/Crystal Therapy at the\u00a0<\/span>Alternative Healing Academy<\/strong><\/a>!\u00a0Convenient and easy-to-handle payment plans are available!<\/span><\/p>\n

\n
\n

Related Articles<\/h2>\n